Advancer Global Limited (SGX:43Q)

Elevation Oncology Balance Sheet

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	23.21	16.29	20.8	24.8	27.62
Short-Term Investments	0.54	0.68	0.82	0.44	0.67
Trading Asset Securities	1.67	2.83	2.91	2.51	1.01
Cash & Short-Term Investments	25.42	19.81	24.52	27.75	29.29
Cash Growth	28.33%	-19.23%	-11.61%	-5.28%	11.59%
Accounts Receivable	7.65	10.48	9.46	9.79	11.49
Other Receivables	1.69	0.33	0.56	0.88	1.92
Receivables	9.63	13.64	12.81	13.31	16.9
Inventory	0.25	0.78	0.87	0.7	1.05
Prepaid Expenses	0.51	0.38	0.33	0.38	0.31
Other Current Assets	0.76	0.58	0.5	0.55	0.78
Total Current Assets	36.57	35.18	39.04	42.68	48.33
Property, Plant & Equipment	2.74	4.76	4.41	3.87	4.63
Long-Term Investments	0.06	0.62	0.41	0.52	1.02
Goodwill	2.85	2.85	2.85	4.43	5.44
Other Intangible Assets	0.53	0.25	0.41	0.54	0.67
Long-Term Deferred Tax Assets	-	-	-	0.03	0.03
Other Long-Term Assets	0.87	-	-	-	-
Total Assets	43.61	43.65	47.12	52.06	60.12
Accounts Payable	1.21	1.35	0.84	0.83	1.12
Accrued Expenses	5.6	6.34	5.48	4.86	5.19
Current Portion of Long-Term Debt	-	0.03	0.03	0.03	0.03
Current Portion of Leases	1.2	1.43	1.46	1.34	1.47
Current Income Taxes Payable	-	-	-	0.02	0.09
Current Unearned Revenue	0.87	0.94	1.04	1.51	1.57
Other Current Liabilities	0.33	0.4	0.38	0.6	1.12
Total Current Liabilities	9.2	10.48	9.22	9.19	10.59
Long-Term Debt	-	0.47	0.5	0.53	0.56
Long-Term Leases	1.08	1.02	1.17	0.7	1.13
Long-Term Deferred Tax Liabilities	0.07	0.08	0.08	0.09	0.12
Total Liabilities	10.35	12.04	10.97	10.51	12.4
Common Stock	40.61	40.61	40.61	40.61	40.61
Retained Earnings	-3.55	-4.9	-0.96	3.35	9.38
Treasury Stock	-0.24	-0.24	-0.24	-0.24	-0.23
Comprehensive Income & Other	-3.46	-3.46	-3.24	-2.85	-2.83
Total Common Equity	33.36	32.01	36.16	40.87	46.92
Minority Interest	-0.11	-0.4	-0.02	0.69	0.8
Shareholders' Equity	33.25	31.61	36.14	41.55	47.72
Total Liabilities & Equity	43.61	43.65	47.12	52.06	60.12
Total Debt	2.28	2.94	3.16	2.6	3.19
Net Cash (Debt)	23.14	16.87	21.36	25.14	26.1
Net Cash Growth	37.21%	-21.05%	-15.03%	-3.67%	16.55%
Net Cash Per Share	0.09	0.07	0.09	0.10	0.10
Filing Date Shares Outstanding	251.19	251.19	251.19	251.19	251.19
Total Common Shares Outstanding	251.19	251.19	251.19	251.19	251.26
Working Capital	27.37	24.71	29.81	33.49	37.74
Book Value Per Share	0.13	0.13	0.14	0.16	0.19
Tangible Book Value	29.99	28.92	32.9	35.9	40.81
Tangible Book Value Per Share	0.12	0.12	0.13	0.14	0.16
Buildings	-	1.75	0.88	0.88	0.88
Machinery	1.01	1.32	1.88	1.79	1.93

Source: S&P Global Market Intelligence. Standard template. Financial Sources.